ACDIMA Participates in 2nd international exhibition on COMPLETE pharma manufacturing

Dear ACDIMA Shareholders,

We invite you to attend the General Assembly meeting of the Arab Company for Pharmaceutical Industries and Medical Appliances (ACDIMA), which will be held at 1:00 PM (Jordan time) on Monday, 26 Rabi` Al-Awwal 1446 AH corresponding to September 30, 2024, via electronic link (Online), where the topics included on the agenda will be considered during the meeting as follows:

1. Approval of the Board of Directors' report on the company's activity during the fiscal year (2022).
2. Approval of the Auditor's report on the final financial statements for the fiscal year ending 12/31/2022.
3. Approval of the Board of Directors' recommendation not to distribute profits due to the company not achieving any profits for the year 2022.
4. Discharging the Board of Directors from liability.
5. Approval of the Board of Directors' recommendation not to pay the Board of Directors' bonus.
6. Approval of the Board of Directors' recommendation to appoint (Talal Abu-Ghazaleh & Co. International) as auditors for the fiscal year ending 12/31/2023 and the fiscal year ending 12/31/2024.

We hope that you name your representative at the above General Assembly meeting and provide him with evidence of his authorization to do so, and provide the company's management with his email address in addition to the mobile number to send the link to enter the meeting (remotely), noting that the Board of Directors' report on the company's activity and the auditor's report on the final financial statements for the year (2022) will be sent as soon as possible.

We take this opportunity to express our sincere thanks to you, hoping that we all succeed in achieving the company's goals.

Please accept our utmost respect and appreciation,

Khaled Ibrahim Al-Rabiah

Chairman of the Board of Directors of

Arab Company for Pharmaceutical Industries

and Medical Appliances (Acdima)

:Attached

كتاب دعوة الجمعية

Tuesday 18/07/2023, the Jordanian Ministry of Health signed a memorandum of cooperation with ACDIMA BioCenter; one of Arab Company for Pharmaceutical Industries and Medical Appliances (ACDIMA) Investments for the purposes of organizing clinical research, attracting research studies locally and internationally, and training health professionals staff to enable them to engage in clinical studies with high efficiency. The MOU was signed by the Jordanian Minister of Health, H.E. Dr. Firas. Al-Hawari and the Executive Director of ACDIMA, Dr. Rabab Tayyem, where ACDIMA is one of the specialized and accredited centers at local and international levels to conduct Clinical studies according to the highest quality standards followed to conduct clinical studies in Advanced countries . Al-Hawari pointed to the importance of this cooperation in providing treatment opportunities that were not available for some diseases, explaining that the Ministry of Health, under the signed memorandum of cooperation, will establish a specialized unit for clinical studies and medical research in cooperation with  ACDIMA Center, through which patients will be able to benefit from specialized and modern quality treatments for rare, incurable and chronic diseases, which the approved treatments are no longer effective in their treatment. He pointed out that this cooperation will enhance the enrichment of Health professionals staff and consolidating the concept of scientific research for them and keeping pace with the work of international institutions in this field and its integration with professional practice.

,Dear ACDIMA Shareholders

We invite you to attend the General Assembly meeting of the Arab Company for Pharmaceutical Industries and Medical Appliances (ACDIMA), which will be held at 11:00 AM on Sunday, 7 Thu Al-Hijjah 1444 AH corresponding to June 25, 2023 AD, via an electronic link (Online) or at the company's headquarters in Amman, the Hashemite Kingdom of Jordan for those who wish to attend, the meeting will consider the topics included in the agenda and as follows:

1- The Board of Directors' report on the company's activities during the fiscal year 2022.

2- The Auditor's report for the fiscal year ending 12/31/2022.

3- Approval of the balance sheet as it is on 12/31/2022.

4- Discharging the Chairman and members of the Board of Directors.

5- The Board of Directors' recommendation not to pay the bonus to the Chairman and members of the Board of Directors.

6- Appointing an external auditor for the company for the years (2023, 2024 and 2025).

We hope to name your representative at the above General Assembly meeting and provide him with evidence of his authorization to do so, and to provide the company's management with his email address in addition to the mobile number to send the link to enter the meeting (remotely), noting that the Board of Directors' report, financial statements and the company's auditor's report for the year (2022) have been attached to this letter, for your kind review.

We take this opportunity to express our sincere thanks to you, hoping that we will all succeed in achieving the company's goals.

Please accept our utmost respect and appreciation,

Adel Karim / Chairman of the Board of Directors of

Arab Company for Drug Industries and Medical Appliances (ACDIMA)

:Attached

كتاب دعوة الجمعية

In the interest of the King Hussein Cancer Foundation to raise awareness about the "Cancer Care Insurance"  to cover cancer treatment, the King Hussein Cancer Foundation, in cooperation with the Arab Company for Drug Industries and Medical Appliances (ACDIMA), helda presentation for employees to introduce the "Cancer Care Insurance" program at the company's headquarters .

Under the patronage of his excellence Dr Zeid R. Kilani, Chairperson of Jordan Pharmacists Association

ACDIMA coordinated the 4th ISoP Middle East Chapter symposium in Acdima headquarters, Amman.

The ISoP Middle East Chapter held their 5th Pharmacovigilance Workshop in November, a twoday meeting in collaboration with MSSO who provided MedDRA training. Many thanks to all involved for a very successful course

Under the patronage of his excellency (HE) Dr Zeid R. Kilani, Chairperson of Jordan Pharmacists Association

ACDIMA participated and sponsored a 2-day scientific workshop entitled “Pharmacogenomics Testing: Toward Personalized Therapy”, that was organized by the scientific committee at Jordan Pharmacists Association (JPA) and in collaboration with MS Pharma and Middle East Molecular Biology Society (MEMBS). The event ,that had more than 90 pharmacists, included different aspects: presentations from expert speakers representing different Jordanian universities, practical workshop on pharmacologists, and discussions from the audience about this important topic which represents one of the future challenges in the pharmaceutical industry.

ACDIMA support for the activities of the Pharmacists Syndicate
An Image showning from the stem cell workshop that was organized by the Scientific Committee of the Pharmacists Syndicate, which was held in ACDIMA

An EXCLUSIVE pharma exhibition in association with AUPAM. 

ACDIMA Participated in the 2nd international exhibition on COMPLETE pharma manufacturing that was held at Amman, JORDAN 

Strategic exposure of untapped potential of the pharma capabilities of Arab Countries
ONE Exhibition - Exposure to buyers of pharma industries from 20 AUPAM Member Countries
More than 600 pharma manufacturing companies among the Arab Member Countries
To position Arab pharma industries on global map
To showcase the strength of the finished products manufacturers by the Arab League Countries
pharmaceutical industries
Networking among the industry:
• Pharma Manufacturers • Importers & Exporters
• Pharma Production Professionals • Govt. Departments
• Pharmacists / Chemists / Retailers • Distributors & Whole-sellers
Exploring the technology upgradations
Access to international markets and an increase in export potential for state based companies
Reduction of marketing costs and other overheads
Displaying the new technologies / product services
Ensuring competitive advantage
Researching of new buyers & markets
To offer updated pharma manufacturing technologies ensuring affordable medicines for all

A new achievement lined the ladder of achievements of ACDIMA

His Excellency Dr. Mohamed Khalil, General Manager of Acdima, laid the foundation stone for a new pharmaceutical factory in Ivory Coast